| Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS (NCT06021210) | The First Affiliated Hospital of Soochow University | 2022-07-07 |
| Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection (NCT04934527) | University Hospital, Bordeaux | 2021-11-17 |
| CMV-TCR-T Cells for Refractory CMV Infection After HSCT (NCT05089838) | Xiao-Jun Huang | 2021-01-06 |
| Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA (NCT05315882) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2020-02-14 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells (NCT03798301) | University of Wisconsin, Madison | 2020-02-06 |
| A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection (NCT04017962) | Memorial Sloan Kettering Cancer Center | 2019-07-19 |
| Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation (NCT02985775) | Peking University People's Hospital | 2017-01-01 |
| CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. (NCT03067155) | University Hospital, Ghent | 2016-10-01 |
| Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02136797) | Memorial Sloan Kettering Cancer Center | 2014-05-08 |
| Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant (NCT02550639) | ORIOL BESTARD | 2014-02-01 |
| MSC for Treatment of CMV Infection (NCT02083731) | Nanfang Hospital, Southern Medical University | 2014-01-01 |
| Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (NCT02988258) | University College, London | 2013-07-01 |
| CMV Modulation of the Immune System in ANCA-associated Vasculitis (NCT01633476) | Professor Lorraine Harper | 2013-07-01 |
| Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study (NCT02843880) | AdministrateurDRC | 2013-03-01 |
| Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation (NCT02779439) | University of Sydney | 2013-01-01 |
| CMV Intensive Care Units (NCT02324244) | Emilio Bouza | 2012-10-01 |
| Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals (NCT00168259) | The Alfred | 2004-12-01 |
| Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) (NCT01945619) | Baylor College of Medicine | |